tradmap

NOC Financials Northrop Grumman

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 2.7% per year over the past 5 years.
  • Net income has grown faster than revenue (5.6% vs 2.7% per year).
  • Operating margin has been roughly flat, at 10.8% in the latest year.
  • Free cash flow has grown 2.8% per year over the past 5 years.

Financial health

  • Total debt ($15.7B) exceeds cash ($4.4B); net debt is $11.3B.
  • Total debt has grown in line with revenue (0.9% vs 2.7% per year).
  • Operating income covered interest expense 6.8× in the latest year, down from 6.9× 5 years ago.
  • Total debt is 2.6× EBITDA.

Shareholder returns

  • Dividends have been paid for 15 consecutive years, consuming 30.9% of earnings and 39.1% of free cash flow.
  • The dividend has grown 6.3% per year over the past 5 years.
Revenue & net income
$0 $21B $42B 2011 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
0% 28% 55% 2011 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Free cash flow (CFO − capex)
$0 $2B $3B 2011 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $8B $16B 2011 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$9B -$959M $7B $0 2011 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MFCFTotal debtCash
2025 $42.0B $4.2B 0.0% 10.8% $3.3B $15.7B $4.4B
2024 $41.0B $4.2B 0.0% 10.6% $2.6B $16.3B $4.4B
2023 $39.3B $2.1B 0.0% 6.5% $2.1B $13.9B $3.1B
2022 $36.6B $4.9B 0.0% 9.8% $1.5B $12.9B $2.6B
2021 $35.7B $7.0B 0.0% 15.8% $2.2B $12.8B $3.5B
2020 $36.8B $3.2B 0.0% 11.0% $2.9B $15.0B $4.9B
2019 $33.8B $2.2B 0.0% 11.7% $3.0B $13.9B $2.2B
2018 $30.1B $3.2B 0.0% 12.6% $2.6B $14.4B $1.6B
2017 $26.0B $2.9B 52.8% 12.4% $1.7B $15.3B $11.2B
2016 $24.7B $2.0B 55.5% 13.3% $1.9B $7.1B $2.5B
2015 $2.0B $1.7B $6.5B $2.3B
2014 $2.1B $2.0B $5.9B $3.9B
2013 $2.0B $2.1B $5.9B $5.2B
2012 $2.0B $2.3B $3.9B $3.9B
2011 $2.1B $1.6B $3.9B $3.0B

Valuation over time

How the market has priced NOC against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 18.2 36.4 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/E
Price / sales (P/S)
0.0 1.2 2.5 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/S
Dividend yield (%)
0.0 0.9 1.8 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
Dividend yield %

Frequently asked questions

Is NOC growing its revenue and profit?

Over the past 5 years, Northrop Grumman's revenue has grown 2.7% per year, and net income grown 5.6% per year. These are computed facts, not advice.

How much debt does NOC have?

As of FY2025, Northrop Grumman reported $15.7B of total debt against $4.4B of cash; operating income covered interest expense 6.8×.

What is NOC's profit margin?

In FY2025, gross margin was —, operating margin 10.8%, and net margin 10.0%.

What is NOC's P/E ratio?

As of Jun '26, Northrop Grumman traded at a price-to-earnings ratio of about 17.0× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.